{"id":"NCT01962987","sponsor":"Actavis Inc.","briefTitle":"A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis","officialTitle":"A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel Design Study Comparing Diclofenac Sodium Gel 3% (Actavis) to Solaraze ® (Diclofenac Sodium) Gel 3% (Fougera Pharms) in the Treatment of Actinic Keratosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-03","primaryCompletion":"2013-09","completion":"2013-09","firstPosted":"2013-10-16","resultsPosted":"2020-07-20","lastUpdate":"2020-07-20"},"enrollment":476,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Actinic Keratosis"],"interventions":[{"type":"DRUG","name":"Diclofenac sodium","otherNames":["Solaraze"]},{"type":"OTHER","name":"Placebo","otherNames":["Vehicle base"]}],"arms":[{"label":"Diclofenac Sodium 3% gel - Test","type":"EXPERIMENTAL"},{"label":"Diclofenac Sodium 3% gel - Reference","type":"ACTIVE_COMPARATOR"},{"label":"Placebo gel","type":"PLACEBO_COMPARATOR"}],"summary":"To compare the relative efficacy and safety of the test formulation diclofenac sodium gel 3% (Actavis) to the marketed formulation Solaraze® (diclofenac sodium) Gel 3% (Fougera Pharms) in the treatment of the actinic keratosis","primaryOutcome":{"measure":"Percentage of Patients With 100% Clearance of All AK Lesions Within the Treatment Area Assessed at Day 90","timeFrame":"90 days","effectByArm":[{"arm":"Diclofenac Sodium 3% Gel","deltaMin":31,"sd":null},{"arm":"Solaraze( Diclofenac Sodium) 3% Gel","deltaMin":32,"sd":null},{"arm":"Vehicle Gel","deltaMin":7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":"0.0010"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":31,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":188},"commonTop":["Headache","Application site dermatitis","Dizziness","Nausea","Application site pain"]}}